Penn Engineering Research and Innovation
Penn Engineering aims to transform medicine from reactive to predictive and personalized care. By integrating AI, biotechnology and immune engineering, our researchers focus on accelerating therapies, enabling early detection and creating regenerative solutions, ultimately improving health outcomes and expanding access to advanced, data-driven care worldwide.
As part of a $100 million investment to develop new laboratories and hire new faculty, the Center for Precision Engineering for Health, or CPE4H, enables Penn Engineers to develop technologies that will fight future pandemics, cure incurable diseases and extend healthy life spans around the world. Areas of research include customizable biomaterials, active implantable MEMS devices and novel delivery mechanisms for individualized diagnostics, treatments and therapies.
Daniel A. Hammer, Alfred G. and Meta A. Ennis Professor in Penn Engineering’s Departments of Bioengineering and Chemical and Biomolecular Engineering, is CPE4H’s inaugural director. In addition to strengthening ties with the Perelman School of Medicine and Penn’s other health schools, Hammer is recruiting a core faculty with expertise in drug delivery vehicles, biomimicry, responsive biodevices and microelectromechanical systems.
